Preclinical development of a first in class therapeutic for treating idiopathic pulmonary fibrosis
Ended Project Grant Awarded Last action
- Award ID
- R43HL145960
- Recipient
-
MDI Therapeutics Inc. UEI T6J4WBXF9EB1
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $225,000
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Place of performance
- Novi, MI 48377, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $225,000 |
Quick answers
Who received award R43HL145960?
R43HL145960 was awarded to MDI Therapeutics Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on January 1, 2019.
How much is award R43HL145960 worth?
$225,000 has been obligated on R43HL145960.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award